1986
DOI: 10.1016/s0003-4975(10)62762-2
|View full text |Cite
|
Sign up to set email alerts
|

Transthoracic versus Extrathoracic Esophagectomy: Mortality, Morbidity, and Long-term Survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
18
0
4

Year Published

1991
1991
2005
2005

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 117 publications
(23 citation statements)
references
References 61 publications
1
18
0
4
Order By: Relevance
“…The rate is equal to that of the mediastinal lower periesophageal nodes, which are the closest lymph nodes to the lesion. In our series, the 5-year survival rate of 33.6% for the patients with positive nodes certainly indicates the positive effect of our lymph node dissection on prognosis, because the rate is not at all inferior to any surgical result reported in the literature, even when investigators included those patients without lymph node metastasis [8,13,14]. Thirteen patients (16.5%) had one positive node, and the significantly better prognosis of those patients with no or one positive node again indicates the positive effect of lymph node dissection on prognosis.…”
Section: Discussionsupporting
confidence: 62%
“…The rate is equal to that of the mediastinal lower periesophageal nodes, which are the closest lymph nodes to the lesion. In our series, the 5-year survival rate of 33.6% for the patients with positive nodes certainly indicates the positive effect of our lymph node dissection on prognosis, because the rate is not at all inferior to any surgical result reported in the literature, even when investigators included those patients without lymph node metastasis [8,13,14]. Thirteen patients (16.5%) had one positive node, and the significantly better prognosis of those patients with no or one positive node again indicates the positive effect of lymph node dissection on prognosis.…”
Section: Discussionsupporting
confidence: 62%
“…In a series of 304 EWT collected by Perrachia and Bardini, the pulmonary complications were as follows: tracheobronchial tear (1.5%), pleural effusion (17.8%), and operative mortality rate 10.3% [I1]. Shahian et al have reported a respiratory morbidity rate higher (although nonsignificantly) after EWT than after open esophagectomy [13]. The technique of endoscopic dissection as described by Kipfm~ller et al seems to be much safer than EWT [4]: their blood loss was five times less, they had no pneumothorax (vs 71%), and the vagus nerves were preserved, avoiding recurrent laryngeal nerve palsy observed in 17% of the patients after EWT [7].…”
Section: Discussionmentioning
confidence: 99%
“…Esophagectomy without thoracotomy (EWT) has been suggested as a way to reduce this morbidity [10]. However, this theorical advantage has not been demonstrated [13], and the procedure may be complicated by mediastinal hemorrage, tracheal tear, and recurrent laryngeal nerve injury [7,9]. In addition, this "blind" dissection cannot remove the periesophageal tissue and the mediastinal nodes.…”
Section: Abstract: Esophagus -Esophagectomy -Vagotomy -Esophageal Mymentioning
confidence: 99%
“…In prospective but nonrandomized studies, Hortsmann et al [34] and Shalian et al [35] have failed to show that transthoracic esophagectomy with systemic two-field lymphadenectomy results in longer survival (Table II). Only one random-assignment study with a limited number of patients has been performed comparing transhiatal and transthoracic esophagectomy, both without any form of extended lymph node dissection.…”
Section: Esophageal Cancermentioning
confidence: 99%
“…In this study, Goldminc et al [36] found that overall survival in either node-negative or node-positive patients was not significantly different (Table II). However, transhiatal esophagectomy is not viewed as a procedure that is easier or safer than transthoracic esophagectomy, but rather as an alternative in the surgical armamentarium [35]. Transthoracic esophagectomy is preferred unless there are significant contraindications [33,37].…”
Section: Esophageal Cancermentioning
confidence: 99%